While the focus of the current situation may be on the loss of patent protection and therefore competition from generics, an added concern may be the potential for the market to contract in the US if the fallacy of using TRT for "lifestyle" rather than medical reasons becomes more understood.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.002(11.1%) |
Mkt cap ! $6.548M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.6¢ | $39.34K | 2.216M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 971151 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 565000 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| ACR (ASX) Chart |